Company Filing History:
Years Active: 2024-2025
Title: Doris Schuetz: Innovator in Proliferative Disease Treatment
Introduction
Doris Schuetz is a prominent inventor based in Montréal, Canada. She has made significant contributions to the field of medicine, particularly in the treatment of proliferative diseases. With a total of 2 patents to her name, her work is recognized for its potential impact on healthcare.
Latest Patents
Doris Schuetz's latest patents focus on Pyrido[3,2-d]pyrimidine compounds. These compounds are designed for use in treating proliferative diseases associated with RAF and RAS gene mutations. The patents detail compounds, compositions, and their applications in addressing these medical conditions. The compounds disclosed are of Formula I or a pharmaceutically acceptable salt or solvate thereof, wherein R, R, R, X, X, X, and X are defined within the patent documentation.
Career Highlights
Doris Schuetz is affiliated with the Université de Montréal, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the medical research community, particularly in the area of cancer treatment.
Collaborations
Doris has collaborated with notable colleagues, including Pierre Louis Beaulieu and Eric Beaulieu. These partnerships have further enhanced her research capabilities and contributed to her success in the field.
Conclusion
Doris Schuetz is a trailblazer in the development of treatments for proliferative diseases, with her innovative patents paving the way for future advancements in medicine. Her contributions are invaluable to the ongoing fight against complex health conditions.